Patient Characteristics (n = 31)
| Characteristic | Data |
|---|---|
| Age (y) | 64.2 ± 9.2 |
| Male sex | 28 (90.3%) |
| Body mass index (kg/m2) | 25.4 ± 4.8 |
| Current smoking | 11 (35.5%) |
| Diabetes mellitus | 3 (9.7%) |
| Hypertension | 13 (41.9%) |
| Hypercholesterolemia | 17 (54.8%) |
| Family history of CAD | 9 (31%) |
| Time from symptoms to PCI (h) | 4.9 ± 6.1 |
| Culprit coronary artery territory | |
| Left anterior descending artery | 15 (48.4%) |
| Circumflex artery | 7 (22.6%) |
| Right coronary artery | 9 (29%) |
| Post-PCI TIMI flow | |
| Grade 2 | 10 (32.3%) |
| Grade 3 | 21 (67.7%) |
| Peak troponin T (ng/L) | 3884.3 ± 4391.7 |
| Peak NT-proBNP (ng/L) | 979.4 ± 871.5 |
| Total cholesterol (mmol/L) | 4.2 ± 1.1 |
| LDL cholesterol (mmol/L) | 2.9 ± 0.9 |
| Duration of hospital stay (d) | 3.7 ± 1.8 |
| Loop diuretics | 10 (32.3%) |
| Inotropic medication | 7 (22.6%) |
| Medication at discharge | |
| Aspirin | 30 (96.8%) |
| Statin | 30 (96.8%)* |
| ACEI/ARB | 29 (93.5%) |
| β-blocker | 25 (80.6%) |
↵* High-intensity statin in 27 (87.1%).
CAD = coronary artery disease; PCI = percutaneous coronary intervention; TIMI = thrombolysis in myocardial infarction; LDL = low-density lipoprotein; ACEI/ARB = angiotensin-converting enzyme inhibitor/angiotensin receptor blocker.
Qualitative data are number and percentage; continuous data are mean ± SD.